3qqu
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | + | [[Image:3qqu.jpg|left|200px]] | |
- | The | + | <!-- |
+ | The line below this paragraph, containing "STRUCTURE_3qqu", creates the "Structure Box" on the page. | ||
+ | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
+ | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
+ | or leave the SCENE parameter empty for the default display. | ||
+ | --> | ||
+ | {{STRUCTURE_3qqu| PDB=3qqu | SCENE= }} | ||
- | + | ===Cocrystal structure of unphosphorylated igf with pyrimidine 8=== | |
- | + | ||
+ | <!-- | ||
+ | The line below this paragraph, {{ABSTRACT_PUBMED_21414779}}, adds the Publication Abstract to the page | ||
+ | (as it appears on PubMed at http://www.pubmed.gov), where 21414779 is the PubMed ID number. | ||
+ | --> | ||
+ | {{ABSTRACT_PUBMED_21414779}} | ||
+ | |||
+ | ==About this Structure== | ||
+ | [[3qqu]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3QQU OCA]. | ||
+ | |||
+ | ==Reference== | ||
+ | <ref group="xtra">PMID:21414779</ref><references group="xtra"/> | ||
+ | [[Category: Homo sapiens]] | ||
+ | [[Category: Receptor protein-tyrosine kinase]] | ||
+ | [[Category: Huang, X.]] |
Revision as of 10:35, 21 April 2011
Cocrystal structure of unphosphorylated igf with pyrimidine 8
Template:ABSTRACT PUBMED 21414779
About this Structure
3qqu is a 4 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Buchanan JL, Newcomb JR, Carney DP, Chaffee SC, Chai L, Cupples R, Epstein LF, Gallant P, Gu Y, Harmange JC, Hodge K, Houk BE, Huang X, Jona J, Joseph S, Jun HT, Kumar R, Li C, Lu J, Menges T, Morrison MJ, Novak PM, van der Plas S, Radinsky R, Rose PE, Sawant S, Sun JR, Surapaneni S, Turci SM, Xu K, Yanez E, Zhao H, Zhu X. Discovery of 2,4-bis-arylamino-1,3-pyrimidines as insulin-like growth factor-1 receptor (IGF-1R) inhibitors. Bioorg Med Chem Lett. 2011 Apr 15;21(8):2394-9. Epub 2011 Feb 23. PMID:21414779 doi:10.1016/j.bmcl.2011.02.075